DNA Markers Distinguish Between Harmless and Deadly Bacteria

Article

The virulent pathogen that causes the disease tularemia, or "rabbit fever," was weaponized during past world wars and is considered a potential bioweapon. Through a new study of the coccobacillus Francisella, Los Alamos National Laboratory researchers are working to use DNA markers to discern related but relatively harmless species as they are identified and to provide a means to distinguish them from the harmful F. tularensis.

Scanning electron micrograph of a murine macrophage infected with Francisella tularensis strain LVS. Macrophages were dry-fractured by touching the cell surface with cellophane tape after critical point drying to reveal intracellular bacteria. Bacteria (colorized in blue) are located either in the cytosol or within a membrane-bound vacuole. Courtesy of NIAID
 
The virulent pathogen that causes the disease tularemia, or "rabbit fever," was weaponized during past world wars and is considered a potential bioweapon. Through a new study of the coccobacillus Francisella, Los Alamos National Laboratory researchers are working to use DNA markers to discern related but relatively harmless species as they are identified and to provide a means to distinguish them from the harmful F. tularensis.

"This large study is particularly notable for having used 31 publicly available genomes plus select genes from about 90 additional isolates," said corresponding author Cheryl Kuske of the Bioenergy & Biome Sciences group at Los Alamos National Laboratory. The paper was published in the current issue of Applied and Environmental Microbiology (AEM).

The group's work includes developing a comprehensive, genomics-based understanding of organisms and their environment as part of the Lab's energy-security research into energy sources and their impact. "We conducted standard single and multi-gene comparisons with whole-genome approaches and identified potential virulence factors to discriminate new species from among the more traditional set. Thanks to coordination with the Centers for Disease Control and Prevention (CDC), we now have a framework to identify new isolates or environmental detections even if only partial information is available," Kuske said.

Humans can easily develop tularemia through incidental contact with infected rabbits, cats, rodents or other animals (and the ticks or fleas that may be on them). The disease manifests in a variety of forms: fever and chills with joint pain, cough or pneumonia, or abdominal pain and distress. Fatality rates range, depending on the form of the disease, from 2 percent to 24 percent, according to CDC data. Due to this severity, the CDC has made tularemia a reportable disease, and like the pathogens causing anthrax and plague, it is considered a bioweapon.

Through detailed genome comparisons, sequence-alignment algorithms and other bioinformatics tools run on Los Alamos computers, the Los Alamos team identified features that differentiate among F. tularensis and other novel clinical and environmental Francisella isolates, providing a knowledge base for comparison of new sequences from clinical or environmental surveys.

"For residents of areas such as the Southwest, where tularemia outbreaks are endemic and potentially life threatening, having more identification tools at hand is extremely valuable," Kuske said. The distribution of these isolates is global, however, suggesting a worldwide distribution of Francisella organisms that inhabit fish, ticks and a variety of environmental sources. The team designated four new species groups within the genus; Francisella opportunistica, an opportunistic pathogen of immune compromised patients; Francisella salina and Francisella uliginis, environmental isolates from coastal seawater near Galveston, TX; and Francisella frigiditurris from cooling-tower water in California.

Source: DOE/Los Alamos National Laboratory

Related Videos
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Related Content